Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day <a target=_blank href= ...
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
According to the FTC, the three largest PBMs — CVS Health’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx — used their power to exclude cheaper insulin products from the menu of ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback